BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, May 18, 2026
Breaking News: Tracking hantavirus across the globeBreaking News: WHO declares Ebola outbreak a public health emergency of international concernBreaking News: WHO declares Ebola outbreak a public health emergency of international concern
Home » Topics » BioWorld Science

BioWorld Science
BioWorld Science RSS Feed RSS

DNA illustration
Biomarkers

Investigators identify novel variants in the KIAA1109 gene related to Alkuraya-Kucinskas syndrome

March 20, 2023
Investigators from the Thomas Jefferson University have presented a case report of a 27-year-old pregnant patient in whom cystic hygroma, extensive anasarca, bilateral pleural effusions, ascites, abnormally curved sacrum and hydrocephalus with parenchymal volume loss, among others were detected by prenatal imaging during pregnancy (onset was at about 21 weeks of gestation).
Read More
3D illustration of brain neuron in lysosomal storage diseases
Biomarkers

Plasma lyso-sphingomyelin as biomarker of response to olipudase alfa in patients with ASMD

March 20, 2023
Acid sphingomyelinase deficiency (ASMD) is a progressive lysosomal storage disease caused by autosomal recessive pathogenic variants in the SMPD1 gene encoding acid sphingomyelinase (ASM). In a recent study, researchers from Albert Einstein College of Medicine aimed to assess the levels of plasma lyso-sphingomyelin, a deacylated form of sphingomyelin, in patients with ASMD pre- and post-treatment with olipudase alfa (recombinant-human acid sphingomyelinase).
Read More
Vaccine vial and syringe
Immuno-oncology

Cancervax's sponsored research program with UCLA on universal cancer vaccine now underway

March 20, 2023
Cancervax Inc.'s sponsored research program with the University of California Los Angeles (UCLA)...
Read More
Biomarkers

Novel compound heterozygous variant in EFL1 found in Shwachman-Diamond syndrome 2

March 20, 2023
Researchers from the University of Utah and collaborators presented data on a case report of...
Read More
Brain and encephalography
Neurology/Psychiatric

BHV-7000 demonstrates efficacy and safety in maximal electroshock seizure rat model

March 20, 2023
Researchers from Biohaven Pharmaceutical Holding Co. Ltd. presented preclinical data for...
Read More
Brain and DNA
Neurology/Psychiatric

Quralis announces program targeting UNC13A mis-splicing for neurodegenerative diseases

March 20, 2023
Quralis Corp. has launched a program that targets UNC13A mis-splicing, a critical genetic alteration...
Read More
Cancer

Macrophages drive invasive breast cancer

March 20, 2023
By Mar de Miguel
T cells do not have the last word in some breast cancers. According to a study from the University of Pittsburgh, the key to estrogen receptor positive (ER+) breast tumors are macrophages, not T cells, and targeting them could prevent immunotherapy failure in this type of cancer.
Read More
Mast cell releasing histamine during allergic response
Immune

Nervous system is unexpected player in anaphylactic shock

March 20, 2023
By Coia Dulsat
When undertaking a study on allergen-induced anaphylaxis in mice, researchers have found that not only the immune but also the nervous system may potentially play a part in the anaphylactic response. In their study published March 17, 2023, in Science Immunology, researchers from Duke University Medical Center reported that mice undergoing anaphylaxis displayed an “extended posture behavior” similar to the one that mice exhibit when exposed to high temperatures.
Read More

Other news to note for March 20, 2023

March 20, 2023
Additional early-stage research and drug discovery news in brief, from: Escient Pharmaceuticals, Evgen Pharma, Ionctura, Propanc Biopharma.
Read More
Awareness ribbon with zebra pattern
Genetic/Congenital

Rare diseases yield genomic secrets through new computational approach

March 17, 2023
By Anette Breindl
By adapting computational methods for dealing with large volumes of data, and slimming down that data, researchers at the Icahn School of Medicine at Mount Sinai have discovered previously unknown genetic associations with 19 rare diseases, and validated three of those associations.
Read More
Previous 1 2 … 1147 1148 1149 1150 1151 1152 1153 1154 1155 … 18071 18072 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 15, 2026.
  • DNA and genome editing illustration

    ASGCT 2026: Directed evolution in gene therapy

    BioWorld
    Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
  • 3D illustration of adeno-associated viruses

    ASGCT 2026: Uncovering the mechanisms of AAV toxicity

    BioWorld
    Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
  • Illustration of tau accumulating in a neuron cell.

    Biogen AD drug shows tau, cognition benefit, despite trial miss

    BioWorld
    Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...
  • Doctor with brain illustration, businessman with dollar sign illustration

    Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal

    BioWorld
    Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing